Thiol-containing cross-linking agent with enhanced steric hindrance.

Area of Science:

• Bioconjugation Chemistry
• Immunotoxin Development
• Pharmacokinetics

Background:

• Conventional cross-linking reagents for ricin A chain immunotoxins result in short in vivo circulating lifetimes.
• Sterically hindered thiolating agents like (acetylthio)succinic anhydride do not sufficiently improve immunotoxin stability.

Purpose of the Study:

• To develop a novel cross-linking strategy to enhance the stability and in vivo circulation time of ricin A chain immunotoxins.
• To synthesize and evaluate a new sterically hindered cross-linker for creating more reduction-resistant disulfide bonds.

Main Methods:

• Synthesis of sulfosuccinimidyl N-[3-(acetylthio)-3-methylbutyryl]-beta-alaninate, a doubly methylated cross-linker.
• Cross-linking of ricin A chain and antibodies using the novel reagent.
• Assessment of disulfide bond stability against reduction.
• Evaluation of in vitro cytotoxicities of the resulting immunotoxins.

Main Results:

• The new cross-linker forms disulfide bonds significantly more resistant to reduction compared to unhindered disulfides.
• Despite the deactivated nature of the thiolating agent, it rapidly and reliably cross-links ricin A chain and antibodies.
• The generated immunotoxins exhibit in vitro cytotoxicities comparable to those achieved with conventional 2-iminothiolane coupling.

Conclusions:

• Steric hindrance in cross-linking reagents can be strategically employed to enhance the stability of immunotoxins.
• The novel doubly methylated cross-linker offers a promising approach for developing more effective and stable immunotoxin-based therapeutics.
• Further in vivo studies are warranted to confirm the improved circulating lifetimes and therapeutic efficacy.